Skip to content
Press Release
FEATURED | May 1, 2026

Jason Chambers Teams Up with the Melanoma Researc...

Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...

5 Minute Read
December 20, 2021

Targeting metabolic vulnerabilities of melanoma me...

The major reason melanoma causes illness and death in patients is because the melanoma cells from the skin can travel to lymph nodes or into the blood which allows them to ...

2 Minute Read
December 20, 2021

Harnessing Epigenetic therapies to License Melanom...

Therapies that inhibit epigenetic modulators can induce a state of “virus mimicry” in cancer cells by activating long-overlooked “junk DNA” of the human genome. Thi...

1 Minute Read
December 20, 2020

CXCL9 as an Immune Anti-Melanoma Therapy in Combin...

A major obstacle to even the best melanoma therapies is that in the majority of cases, the tumor never completely goes away. Even if a little bit remains, called the minima...

3 Minute Read
December 20, 2020

Identification of Metastatic Modulators through Ze...

Melanomas arise from pigmented cells called melanocytes, typically in the skin. Melanomas can spread to distal parts of the body, through a process called metastasis. Metas...

3 Minute Read
December 20, 2020

Elucidating Metabolic Changes that Occur in Melano...

Melanoma is the third most common malignancy to metastasize to the brain. It is estimated that at least 50% of patients with stage IV melanoma will develop brain metastases...

2 Minute Read
December 20, 2019

Therapeutic Strategies to Induce Dormancy in Disse...

Metastasis is the main cause of melanoma death. Current treatments mostly fail to cure metastasis. It is of common knowledge that disseminated cancer cells (DCCs)...

2 Minute Read
December 20, 2019

Role of PRAME in Epigenetic Reprogramming and Chro...

UM has a propensity to undergo early micrometastasis prior to treatment of the primary tumor, with later emergence of overt metastatic disease. Unfortunately, the...

2 Minute Read
December 20, 2019

Augmenting Melanoma Response to Immunotherapy via ...

Cancer immunotherapy (CI) drugs activate our own immune system to directly kill cancer cells. These drugs have revolutionized how we treat many cancers including melanoma....

2 Minute Read
December 20, 2019

SOX10 Role in WT BRAF Melanoma

Career Development Award – Claudia Capparelli, PhD

1 Minute Read
December 23, 2018

Targeting KDM5 Histone Demethylases to Boost Immun...

Description: The goal of this research is to target KDM5s family proteins to enhance the response to immune checkpoint inhibition in melanoma. The recently developed immune...

1 Minute Read
December 20, 2018

Targeting HDAC8 to Overcome the Acquisition of Dru...

There has been great progress in increasing the treatment options for patients who have the skin cancer melanoma in the past decade. However, the melanoma will mo...

2 Minute Read
December 20, 2018

Using the ESC-GEMM Approach to Study Mucosal Melan...

Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...

2 Minute Read

Oct 04, 2026 PT

Seattle Miles for Melanoma 5K

Oct 04, 2026 PT

Los Angeles Miles for Melanoma 5K

Oct 05, 2026 ET

Mulligans for Melanoma

Oct 15, 2026 ET

25th Annual New York Gala

Oct 17, 2026 PT

San Diego Miles for Melanoma 5K

Oct 22, 2026 ET

6th Annual #GetNakedJax

Nov 08, 2026 ET

Atlanta Miles for Melanoma 5K

Explore Events